LONDON, Dec 10 (Reuters) - Plans by GlaxoSmithKline Plc to market two long-lasting versions of its Requip medicine in the United States suffered a double blow on Monday. Europe's biggest drugmaker ...

Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat symptoms of Parkinson's disease. This product will be marketed and sold under the Elite Laboratories label ...

April 30, 2007 — Health Canada has approved an expanded indication for atorvastatin calcium tablets, allowing their use to reduce the risk for myocardial infarction in adult patients without ...

Ropinirole (as HCl) 2mg, 4mg, 6mg, 8mg, 12mg; ext-rel tabs. Swallow whole. Initially 2mg once daily for 1–2 weeks, then increase by 2mg/day at ≥1-week intervals up to max 24mg/day (for advanced ...

An early clinical trial headed by researchers at Keio University School of Medicine has shown that the Parkinson’s disease drug ropinirole is safe to use in patients with the fatal motor neuron ...